As of Jul 02
| +0.29 / +0.84%|
The 10 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 38.00, with a high estimate of 42.00 and a low estimate of 31.00. The median estimate represents a +8.98% increase from the last price of 34.87.
The current consensus among 10 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.